About Robert Bettigole
Robert Bettigole is a director of Allyx Therapeutics. Allyx develops oral medicines to protect brain-cell connections in Alzheimer’s disease and other neurodegenerative conditions. He is also a lecturer in the practice of management at Yale School of Management.
In 2018, he signed an Arvinas agreement as managing partner of Elm Street Ventures. He previously held five board roles, including AxioMx, Occam Sciences and Retail Optimization.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Robert Bettigole in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Bettigole works with at each company, as listed on that company's latest Form D.
